JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lau, H. S.
Right arrow Articles by Smith, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lau, H. S.
Right arrow Articles by Smith, D. E.

Effect of probenecid on the dose-response relationship of bumetanide at steady state

HS Lau, LJ Shih and DE Smith

The present investigation was undertaken to clarify the determinants of the pharmacologic responses to bumetanide. The urinary excretion rate, plasma concentration and natriuretic and diuretic effects of bumetanide were evaluated under steady-state conditions in four mongrel dogs, before (Treatment I) and after (Treatment II) probenecid administration. To avoid fluid and electrolyte imbalance, urinary losses were replaced i.v. by equal volumes of lactated Ringer's solution over the time interval of the subsequent collection period. Probenecid administration caused a dramatic reduction in the renal clearance of bumetanide (5.05 +/- 1.11 for Treatment I vs. 0.716 +/- 0.285 ml/min . kg for Treatment II; P less than .002), resulting in significantly higher plasma concentrations (3-fold) and significantly lower urinary excretion rates (2.5-fold) of the diuretic. This was accompanied by concomitant reductions in bumetanide-induced diuresis and natriuresis. The results from this study demonstrate that adequate luminal levels of bumetanide are required for the pharmacodynamics of the drug.

Volume 227, Issue 1, pp. 51-54, 10/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
H. Tahara, H. Kusuhara, H. Endou, H. Koepsell, T. Imaoka, E. Fuse, and Y. Sugiyama
A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 337 - 345.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. C. Brater
Diuretic Therapy
N. Engl. J. Med., August 6, 1998; 339(6): 387 - 395.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.